SPY
766.62
−0.02%
QQQ
689.02
−0.42%
BTC/USD
80,586.00
+0.20%
DIA
534.30
+0.22%
GLD
374.79
+0.62%
TLT
81.92
+0.20%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Imunon Inc
IMNN
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.9070
0.007
0.78%
Last update: Nov 4, 8:14 AM
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Compare
Stock Report
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Earnings:
Q3 2026 Earnings in 8 days from now on Thu Nov 12th, before the market open
Conference Call:
Conference call scheduled in 8 days at 11:00 AM
Click to view the webcast
Imunon Financials
Imunon (IMNN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Imunon Q2 EPS $(0.54) Beats $(0.93) Estimate
Imunon (NASDAQ:IMNN) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.93) by 41.94 percent. This is a 74.88 percent increase over losses of $(2.15) per share from the same
Benzinga Newsdesk
PRO
Imunon Q1 EPS $(0.84) Beats $(1.07) Estimate
Imunon (NASDAQ:IMNN) reported quarterly losses of $(0.84) per share which beat the analyst consensus estimate of $(1.07) by 21.5 percent. This is a 73.33 percent increase over losses of $(3.15) per share from the same
Benzinga Newsdesk
Earnings Scheduled For May 12, 2026
Benzinga Insights
PRO
Imunon Q4 EPS $(1.30) Misses $(1.13) Estimate
Imunon (NASDAQ:IMNN) reported quarterly losses of $(1.30) per share which missed the analyst consensus estimate of $(1.13) by 15.04 percent. This is a 56.67 percent increase over losses of $(3.00) per share from the same
Benzinga Newsdesk
Earnings Scheduled For March 31, 2026
Benzinga Insights
PRO
Imunon Q3 EPS $(1.16) Beats $(1.80) Estimate
Benzinga Newsdesk
